BIO International Convention
Boston, USA
16 June 2025 - 19 June 2025
Want to get in touch?
Northern Ireland at BIO International Convention
Northern Ireland is proud to be represented at this year’s BIO International Convention by ten leading organisations from across our life and health sciences sector - including innovative companies and world-class university research centres. Supported by Invest Northern Ireland, the delegation showcases the region’s strengths in cutting-edge research, advanced technologies, and global collaboration.
Meet the team and hear how Northern Ireland is helping shape the future of health.
Visit us on stand 765.
If you would like to schedule a meeting, you can contact us
To find out more about Northern Ireland’s bio and pharma capabilities, visit our life and health sciences page
Companies attending
-
AilseBio, an oncology-focused company, have developed TiNA Discovery™ - a computational proprietary discovery platform, which unlocks a repertoire of therapy induced transcripts within the dark genome and beyond to identify a distinct class of novel antigens which represent a new frontier for Cancer Immunotherapy: Therapy Induced Novel Antigens (TiNAs).
-
AMPLY Discovery is powering the discovery of new cures for complex diseases such as cancer, metabolic disease, and infectious diseases, through AI and synthetic biology - making the discovery of new next-generation biologic medicines more predictable and less expensive.
-
Celerion is a global leader in early phase clinical research services. For over 50 years, Celerion has leveraged the latest operational concepts and technologies to execute clinical pharmacology studies across its three Phase 1 units in the US and Northern Ireland.
-
CV6 Therapeutics is a clinical-stage biotech developing first-in-class small molecule therapies targeting oncology and inflammatory diseases. The company’s lead asset, CV6-168, is in a Phase 1a trial for solid tumors, with strong combination potential. CV6 Therapeutics is seeking $55M to advance clinical trials and expand its pipeline.
-
The Future Medicines Institute at Queen's University Belfast’s mission is to provide an industry-focused hub for research, innovation, and skills, enhancing Northern Ireland's sustainability while translating cutting-edge scientific discoveries into practical solutions that improve patient outcomes and enhance quality of life.
-
MediNect Ophtho is Europe’s fastest-growing retinal disease partnership research company. The company offers bespoke preclinical studies—including PK/PD, efficacy, and in vitro assays - using advanced models like Subretinal Fibrosis and Dry AMD (CSPA). Partner with MediNect Ophtho for collaborative, expert-led research that supports go/no-go decisions in therapeutic development.
-
MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner.
-
SciLeads is a lead generation platform that maps the world's scientific research and biotech industry; helping sales and marketing teams quickly locate potential customers. SciLeads was started by 3 friends from Belfast and the company has grown to now have 90 fully remote-working staff and thousands of global users.
-
SignaCor is a clinical stage, drug development company, spun-out from Queen’s University Belfast, dedicated to the treatment of cardiac disease. SignaCor is pioneering a first-in-class therapeutic approach to symptomatic hypertrophic cardiomyopathy (HCM) - one that goes beyond symptom management to target the underlying disease pathology.
-
Ulster University has a strong track record of delivering impact from life science research through formation and nurturing of spin-out companies. Through its wholly-owned venturing arm, Innovation Ulster Limited, businesses and individuals can collaborate with Ulster to develop research with commercial potential or invest in spin-out companies.
Contact us
If you are interested in more information on our trade events, contact our Business Support Team on 0800 181 4422 or complete the enquiry form.